A Study to Evaluate Minoxidil for Treatment of Hair Loss in Patients with Breast Cancer on Endocrine Therapy
Official Title
A Pilot Trial of Topical vs Oral Minoxidil for Treatment of Endocrine Therapy-Induced Alopecia in Breast Cancer Patients
Purpose
The purpose of this study is to evaluate the efficacy of minoxidil.
Could this study be right for you?
-
Subjects must have a diagnosis of breast cancer stages I-IV
-
Subjects must have hair loss while on endocrine therapy (i.e., tamoxifen or an aromatase inhibitor such as anastrozole)
-
Subjects must not be on chemotherapy or have been on chemotherapy within 2 years
-
Subjects must not have tried oral or topical minoxidil or spironolactone previously
-
Female subjects must not be pregnant, breastfeeding, or considering becoming pregnant for the duration of the study